Related Experiment Video
Updated: Jan 3, 2026

08:21
Forming Micro-and Nano-Plastics from Agricultural Plastic Films for Employment in Fundamental Research Studies
Published on: July 27, 2022
4.7K
Polystyrene microplastic particles: In vitro pulmonary toxicity assessment.
Cheng-Di Dong1, Chiu-Wen Chen1, Yi-Chun Chen2
1Department of Marine Environmental Engineering, National Kaohsiung University of Science and Technology, Kaohsiung, 81157, Taiwan.
Journal of Hazardous Materials
|November 16, 2019
Summary
Inhaled polystyrene microplastics (PS-MPs) harm human lung cells by causing inflammation and barrier damage. Exposure may increase the risk of respiratory diseases like COPD.
Area of Science:
- Environmental Science
- Toxicology
- Cell Biology
Background:
- Microplastics (MPs), particularly polystyrene (PS-MPs), are pervasive environmental pollutants.
- Atmospheric transport allows MPs to reach remote areas, raising concerns about inhalation exposure.
- The pulmonary toxicity and underlying mechanisms of inhaled MPs require further investigation.
Purpose of the Study:
- To investigate the toxic effects of polystyrene microplastics (PS-MPs) on human lung epithelial cells (BEAS-2B).
- To elucidate the cellular mechanisms responsible for PS-MP-induced pulmonary toxicity.
Main Methods:
- Exposure of normal human lung epithelial BEAS-2B cells to varying concentrations of PS-MPs.
- Assessment of cytotoxicity, inflammatory responses, reactive oxygen species (ROS) formation, and transepithelial electrical resistance (TEER).
- Measurement of zonula occludens protein levels and α1-antitrypsin concentration.
Main Results:
- PS-MPs induced significant cytotoxic and inflammatory effects in BEAS-2B cells.
- Exposure to PS-MPs led to increased reactive oxygen species (ROS) formation.
- PS-MPs disrupted the lung epithelial barrier by depleting zonula occludens proteins and decreasing TEER.
- Decreased α1-antitrypsin levels were observed, suggesting an increased risk for chronic obstructive pulmonary disease (COPD).
Conclusions:
- Inhalation of PS-MPs can adversely affect human respiratory health.
- PS-MPs induce lung epithelial cell damage through oxidative stress and barrier disruption.
- Even low concentrations of PS-MPs can compromise the pulmonary barrier, potentially increasing lung disease risk.

